Concepedia

Helen Browne

HB

Statistics

Publications

8

Citations

954

H-Index

8

Active since

2001

Affiliations

Granta Design (United Kingdom)(Current)

University of Nottingham

Helen Browne is an author at Granta Design (United Kingdom) specializing in pharmacology, medicinal chemistry, and medicine.

Publications per year

2001–2016

8

Publications

8

Antitumor Benzothiazoles. 14. Synthesis and in Vitro Biological Properties of Fluorinated 2-(4-Aminophenyl)benzothiazoles

Ian Hutchinson, Mei‐Sze Chua, Helen Browne et al. · Journal of Medicinal Chemistry · 2001 · 353 citations

, , +8

A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells

Andrew J. Massey, D.S. Williamson, Helen Browne et al. · Cancer Chemotherapy and Pharmacology · 2009 · 329 citations · Full text

, , +16

In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles

Tracey D. Bradshaw, Helen Browne, Valentina Trapani et al. · British Journal of Cancer · 2002 · 69 citations · Full text

, , +14

Antitumor benzothiazoles. Frontier molecular orbital analysis predicts bioactivation of 2-(4-aminophenyl)benzothiazoles to reactive intermediates by cytochrome P4501A1Part 23. For part 22 see Ref. 1.

Sean O’Brien, Helen Browne, Tracey D. Bradshaw et al. · Organic & Biomolecular Chemistry · 2003 · 53 citations

, , +14

Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers

Stephen Pawsey, Mike Wood, Helen Browne et al. · Drugs in R&D · 2016 · 50 citations · Full text

, , +11

1–5 of 8